These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 20213764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Ali S, Banerjee S, Ahmad A, El-Rayes BF, Philip PA, Sarkar FH.
    Mol Cancer Ther; 2008 Jun; 7(6):1708-19. PubMed ID: 18566242
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.
    Ali S, El-Rayes BF, Sarkar FH, Philip PA.
    Mol Cancer Ther; 2005 Dec; 4(12):1943-51. PubMed ID: 16373709
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB.
    El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2006 Nov 01; 66(21):10553-9. PubMed ID: 17079479
    [Abstract] [Full Text] [Related]

  • 5. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081
    [Abstract] [Full Text] [Related]

  • 6. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.
    Zhou L, Qi L, Jiang L, Zhou P, Ma J, Xu X, Li P.
    AAPS J; 2014 Mar 15; 16(2):246-57. PubMed ID: 24424498
    [Abstract] [Full Text] [Related]

  • 9. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.
    Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B.
    J Cancer Res Clin Oncol; 2012 May 15; 138(5):785-97. PubMed ID: 22270965
    [Abstract] [Full Text] [Related]

  • 10. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
    Bianco C, Giovannetti E, Ciardiello F, Mey V, Nannizzi S, Tortora G, Troiani T, Pasqualetti F, Eckhardt G, de Liguoro M, Ricciardi S, Del Tacca M, Raben D, Cionini L, Danesi R.
    Clin Cancer Res; 2006 Dec 01; 12(23):7099-107. PubMed ID: 17145834
    [Abstract] [Full Text] [Related]

  • 11. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
    Kirane A, Toombs JE, Ostapoff K, Carbon JG, Zaknoen S, Braunfeld J, Schwarz RE, Burrows FJ, Brekken RA.
    Clin Cancer Res; 2012 Sep 15; 18(18):5031-42. PubMed ID: 22829202
    [Abstract] [Full Text] [Related]

  • 12. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines.
    Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH.
    Cancer; 2009 May 15; 115(10):2165-76. PubMed ID: 19288574
    [Abstract] [Full Text] [Related]

  • 13. Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts.
    Iwai T, Moriya Y, Shirane M, Fujimoto-Ouchi K, Mori K.
    Oncol Rep; 2012 Apr 15; 27(4):923-8. PubMed ID: 22209766
    [Abstract] [Full Text] [Related]

  • 14. Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer.
    Lin J, Wu H, Shi H, Pan W, Yu H, Zhu J.
    PLoS One; 2013 Apr 15; 8(10):e76169. PubMed ID: 24155892
    [Abstract] [Full Text] [Related]

  • 15. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.
    Liu A, Chen H, Tong H, Ye S, Qiu M, Wang Z, Tan W, Liu J, Lin S.
    Mol Med Rep; 2011 Apr 15; 4(2):221-7. PubMed ID: 21468555
    [Abstract] [Full Text] [Related]

  • 16. Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling.
    Qian Y, Yang B, Xiong Y, Gu M.
    Oncol Rep; 2016 Sep 15; 36(3):1517-25. PubMed ID: 27459907
    [Abstract] [Full Text] [Related]

  • 17. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway.
    Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng Y, Lv J, Song Z, Li Y, Ji L, Pan S, Jiang H, Sun B.
    Biochem Pharmacol; 2014 Apr 01; 88(3):322-33. PubMed ID: 24522113
    [Abstract] [Full Text] [Related]

  • 18. Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.
    Nagaraj NS, Washington MK, Merchant NB.
    Clin Cancer Res; 2011 Feb 01; 17(3):483-93. PubMed ID: 21266529
    [Abstract] [Full Text] [Related]

  • 19. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH, Xue A, Julovi SM, Pavlakis N, Samra JS, Hugh TJ, Gill AJ, Peters L, Baxter RC, Smith RC.
    Clin Cancer Res; 2014 Aug 01; 20(15):4047-58. PubMed ID: 24895459
    [Abstract] [Full Text] [Related]

  • 20. Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells.
    Sloss CM, Wang F, Liu R, Xia L, Houston M, Ljungman D, Palladino MA, Cusack JC.
    Clin Cancer Res; 2008 Aug 15; 14(16):5116-23. PubMed ID: 18698029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.